Digital Look

Welcome to Digital Look++,
you are not logged in

SkinBioTherapeutics (SBTX)

Pharma and Biotech

16.64p

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
31-Dec-24	Interim	1.58	(1.04)	(0.46)p	n/a

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Jun-20	n/a	(1.62)	(1.17)p	n/a	n/a	n/a	n/a	0.0%
30-Jun-21	n/a	(1.50)	(0.01)p	n/a	n/a	n/a	n/a	0.0%
30-Jun-22	0.07	(2.99)	(1.78)p	n/a	n/a	n/a	n/a	0.0%
30-Jun-23	0.13	(3.01)	(1.72)p	n/a	n/a	n/a	n/a	0.0%
30-Jun-24	1.21	(2.95)	(1.54)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts data is not available for this company.

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.